LDL-C testing after an MI is low in Medicare beneficiaries, with disparities by race/ethnicity, region and insurance type. Reinstating LDL-C measurement as a quality metric may be warranted. #healthcare #heartattack
https://t.co/qPGcr2xNrD
Very nice interview with Dr. Bittner about the importance of measuring low-density lipoprotein cholesterol following MI Hospitalization https://www.acc.org/latest-in-cardiology/articles/2024/03/19/13/09/accel-lite-19mar2024
Only 27% of Americans have their LDL-C tested within 90 days of a heart attack hospitalization. H. Res. 709 and S. Res. 496 designated Sep 2023 as “National Cholesterol Education Month” and Sep 30, 2023, as #LDLC_Awareness_Day https://www.congress.gov/bill/118th-congress/senate-resolution/496
Our new research article published in JAMA Cardiology challenges the need to include race in cardiovascular risk prediction.
https://jamanetwork.com/journals/jamacardiology/article-abstract/2812754
LDL-C testing after an MI is low in Medicare beneficiaries, with disparities by race/ethnicity, region and insurance type. Reinstating LDL-C measurement as a quality metric may be warranted. #healthcare #heartattack
https://t.co/qPGcr2xNrD
Internist, epidemiologist
Scientist II at the Department of Epidemiology in the University of Alabama at Birmingham (UAB) School of Public Health.
Fogarty International Clinical Research Fellow in Global Health (2009-2010)
Fulbright scholar (2012-2014)